Status:

COMPLETED

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Chronic Pain

Eligibility:

All Genders

2-18 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the effectiveness and safety of Durogesic® (a transdermal patch delivering the narcotic pain-reliever fentanyl) in the treatment of children with chronic pain r...

Detailed Description

The objective of this study is to establish the analgesic efficacy, safety and pharmacokinetic profile of Durogesic® in the treatment of pediatric patients with chronic pain requiring long-term opioid...

Eligibility Criteria

Inclusion

  • Patients with a confirmed malignancy (whose pain is judged by the investigator to be caused by the malignancy), or patients with other life-threatening/terminal disease whose pain requires treatment with strong opioid analgesia
  • requiring treatment of pain with a strong opioid and who are expected to continue to require treatment with a strong opioid for the duration of the study
  • receiving a stable dose of immediate-release oral morphine or sustained-release morphine (minimum daily dose of morphine is 30 mg/day) for at least 48 hours immediately prior to entry into the study

Exclusion

  • Patients with a history of allergy or hypersensitivity to fentanyl or morphine
  • have active skin disease that precludes application of Durogesic® or which may affect the absorption of fentanyl
  • have a clinical condition that in the investigator's judgment prevents participation in the study
  • have participated in any other drug trial relating to pain control within one month of study entry
  • currently participating in any other study or research project which would interfere with this trial.

Key Trial Info

Start Date :

February 1 1996

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 1998

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT00271453

Start Date

February 1 1996

End Date

October 1 1998

Last Update

May 18 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.